Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,648 INR | +0.14% | +4.25% | +24.54% |
04-24 | Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility | MT |
04-22 | INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.54% | 8.98B | |
+30.25% | 699B | |
+25.07% | 571B | |
-4.59% | 364B | |
+18.34% | 326B | |
+2.81% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.68% | 154B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- NICE Recommends Lupin’s Namuscla (Mexiletine) for Treatment of Muscle Disorder